About Us

OUR GOAL

Pharma Kiosks was formed in August 2018 with a goal of introducing millions of Las Vegas tourists and thousands of local residents to our patented biometric vending machines selling the best  CBD products in the USA. We have tested hundreds of brands of CBD products and selected the top products in each CBD category to sell in our vending machines. We will add new products and discontinue products from our machines as new leaders and new products emerge. We plan to let the public tell us which brands they want us to carry based on queries and surveys from visitors to our cbdpharmacy.com website which lists all brands of CBD sold in the USA and tracks the responses of its site visitors.

Our 2019 goal is to place 50 vending machines in the McCarran Airport, major resort hotels and casinos, high-end shopping malls, major pharmacy chains, quick care clinics, and other high traffic tourist locations.   When Las Vegas tourists return to virtually every city and country in the world, we hope they will re-order their CBD products from our website for free home delivery and additional discounts based on automatic subscription orders.   Once we have conquered Las Vegas, we hope to enter into national contracts to place thousands of vending machines in major pharmacies, grocery stores, shopping malls, and health, wellness and beauty centers.

We believe it is possible to install 3,000 vending machines or more in the next 1-3 years and achieve hundreds of millions of dollars of profitable revenue.  Our goal is to do an IPO once we have demonstrated the potential of becoming the largest CBD distributor in Las Vegas with the potential of becoming one of the largest CBD distributors of top CBD brands in the world.

OUR TEAM

Founder & Consultant - Larry Stockett, Director of the IPO Network, Consultant - 40 years experience as former Officer and director of 8 public companies.

President - David Knight - Co-owner of ACTVUS.com producer of the CBD Show

Chief Operating Officer - Ryan Vincent- Author of passport, former owner of 4 Colorado dispensaries, ……. of Cannabition Museum in Las Vegas.

Chief Financial Officer - Tran Aleman -  Wealth Manager for family-owned billion dollar business

Corporate Counsel and Corporate Secretary - David LeGrand - Counsel to Shango & NeuroXPF CBD companies.

Website, B2b, B2c, App Development, and API development- Deepak Wadhwani

CBDPharmacy.com - Greg Gillham - Hemp and marijuana grower in Oregon for 20 years.

Biometric Vending Machine Patent Inventor - Robert Tomassi (RIP 2019)

OUR VISION FOR THE CBD INDUSTRY

The Past

The legal CBD industry was created with the passage of the Farm Bill in 2014.  Until then, CBD was considered a Schedule 1 drug like marijuana, heroin, or cocaine.  It was illegal in all 50 states and federally in the USA. Hemp is a cannabis plant similar to marijuana but without the psychoactive ingredient known as THC.  CBD is one of the chemicals that is derived from the hemp plant but must contain less than .03% THC to legally be sold under current laws.

With the passage of the 2014 Farm Bill by Congress, it became legal to grow hemp for the first time in 75 years which allowed CBD products to be manufactured and sold under certain regulations and conditions.  Many marijuana growers quickly jumped into the industry and started creating CBD products which contain less than .03% THC (the psychoactive ingredient in marijuana that gets you high). These products were produced in many forms including oils, tinctures, sprays, edibles, salves, balms, shampoos, cosmetic products, vapes, pre-rolls,  hemp flowers, teas, coffees, beers, water, and other products infused with CBD.

The primary benefits and consumer applications for these CBD products have been for health, wellness, and beauty.  Pain, stress, anxiety, glaucoma, Parkinsons, acne, and many other ailments have been treated with CBD products and consumers continue to use them month after month, paying high prices and attesting to their benefits.

The first CBD companies to enter the market saw rapid sales growth and little to no regulations, no license fees, and the ability to sell their products over the internet.  The US industry grew from under $100 million in 2015 to $250 million in 2016, to $450 million in 2017

to over $800 million in 2018.

In late 2018, with the passage of the 2018 Farm Bill, Hemp was removed from the Schedule 1 drug list and regulation was transferred from the DEA to the FDA.  It will now be regulated as a food and beverage. Those regulations have yet to be finalized, leaving uncertainty of the legality of any food and beverage or health food supplement containing CBD.